Edition:
United States

Insider Trading: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

354.05DKK
23 Aug 2019
Change (% chg)

kr.-0.80 (-0.23%)
Prev Close
kr.354.85
Open
kr.354.40
Day's High
kr.355.70
Day's Low
kr.353.40
Volume
148,667
Avg. Vol
2,470,694
52-wk High
kr.356.50
52-wk Low
kr.265.15

All Insider Trades

Institutional Holders

% Shares Owned: 31.94%
# of Holders: 804
Total Shares Held: 594,951,014
3 Mo. Net Change: 5,825,941
# New Positions: 21
# Closed Positions: 7
# Increased Positions: 184
# Reduced Positions: 160
# Net Buyers: 24

Officers & Directors

Name Age Since Current Position

Helge Lund

56 2018 Independent Chairman of the Board

Lars Fruergaard Joergensen

52 2017 President, Chief Executive Officer

Jeppe Christiansen

59 2013 Vice Chairman of the Board

Karsten Munk Knudsen

47 2018 Chief Financial Officer, Executive Vice President

Maziar Doustdar

48 2015 Executive Vice President, International Operations

Mads Krogsgaard Thomsen

58 2000 Chief Science Officer, Executive Vice President

Lars Green

52 2017 Executive Vice President, Business Services & Compliance

Ludovic Helfgott

2019 Executive Vice President of Biopharm

Doug Langa

52 2017 Executive Vice President, North America Operations

Camilla Sylvest

46 2017 Executive Vice President, Commercial Strategy & Corporate Affairs

Henrik Wulff

48 2015 Executive Vice President, Product Supply

Mette Boejer Jensen

43 2018 Director, Employee Representative

Laurence Debroux

49 2019 Director

Kasim Kutay

54 2017 Director

Anne Kverneland

62 2000 Director, Employee Representative

Thomas Rantzau

46 2018 Director, Employee Representative

Stig Stroebaek

55 1998 Director, Employee Representative

Brian Daniels

60 2016 Independent Director

Andreas Fibig

57 2018 Independent Director

Sylvie Gregoire

57 2015 Independent Director

Liz Hewitt

62 2012 Independent Director

Martin Mackay

63 2018 Independent Director

Peter Hugreffe Ankersen

2015 Corporate Vice President & Head of Investor Relations